Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Olaf Holtkötter is active.

Publication


Featured researches published by Olaf Holtkötter.


Journal of Cell Science | 2006

Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species

Bahar Cat; Dominik Stuhlmann; Holger Steinbrenner; Lirija Alili; Olaf Holtkötter; Helmut Sies; Peter Brenneisen

Myofibroblasts, pivotal for tumor progression, populate the microecosystem of reactive stroma. Using an in vitro tumor-stroma model of skin carcinogenesis, we report here that tumor-cell-derived transforming growth factor β1 (TGFβ1) initiates reactive oxygen species-dependent expression of α-smooth muscle actin, a biomarker for myofibroblastic cells belonging to a group of late-responsive genes. Moreover, protein kinase C (PKC) is involved in lipid hydroperoxide-triggered molecular events underlying transdifferentiation of fibroblasts to myofibroblasts (mesenchymal-mesenchymal transition, MMT). In contrast to fibroblasts, myofibroblasts secrete large amounts of hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6), resulting in a significant increase in the invasive capacity of tumor cells. The thiol N-acetyl-L-cysteine, the micronutrient selenite as well as selenoprotein P and the lipid peroxidation inhibitors α-tocopherol and butylated hydroxytoluene significantly lower both the number of TGFβ1-initiated myofibroblasts and the secretion of HGF, VEGF and IL-6, correlating with a diminished invasive capacity of tumor cells. This novel concept of stromal therapy, namely the protection of stromal cells against the dominating influence of tumor cells in tumor-stroma interaction by antioxidants and micronutrients, may form the basis for prevention of MMT in strategies for chemoprevention of tumor invasion.


International Journal of Cosmetic Science | 2005

Unveiling the molecular basis of intrinsic skin aging1

Olaf Holtkötter; Kordula Schlotmann; H. Hofheinz; R. R. Olbrisch; Dirk Petersohn

The process of skin aging is a combination of an extrinsic and intrinsic aspect, and knowing the molecular changes underlying both is a prerequisite to being able to effectively counter it. However, despite its importance for a deeper understanding of skin aging as a whole, the process of intrinsic skin aging in particular has barely been investigated. In this study, the molecular changes of intrinsic skin aging were analyzed by applying ‘Serial Analysis of Gene Expression’ (SAGETM) to skin biopsies of young and aged donors. The analysis resulted in several hundred differentially expressed genes with varying statistical significance. Of these, several genes were identified that either have never been described in skin aging before (e.g. APP) or have no identified function, e.g. EST sequences. This is the first time that intrinsic skin aging has been analyzed in such a comprehensive manner, offering a new and partially unexpected set of target genes that have to be analyzed in more detail in terms of their contribution to the skin aging process.


Experimental Dermatology | 2016

A three-dimensional skin equivalent reflecting some aspects of in vivo aged skin.

Johanna Diekmann; Lirija Alili; Okka Scholz; Melanie Giesen; Olaf Holtkötter; Peter Brenneisen

Human skin undergoes morphological, biochemical and functional modifications during the ageing process. This study was designed to produce a 3‐dimensional (3D) skin equivalent in vitro reflecting some aspects of in vivo aged skin. Reconstructed skin was generated by co‐culturing skin fibroblasts and keratinocytes on a collagen–glycosaminoglycan–chitosan scaffold, and ageing was induced by the exposition of fibroblasts to Mitomycin‐C (MMC). Recently published data showed that MMC treatment resulted in a drug‐induced accelerated senescence (DIAS) in human dermal fibroblast cultures. Next to established ageing markers, histological changes were analysed in comparison with in vivo aged skin. In aged epidermis, the filaggrin expression is reduced in vivo and in vitro. Furthermore, in dermal tissue, the amount of elastin and collagen is lowered in aged skin in vivo as well as after the treatment of 3D skin equivalents with MMC in vitro. Our results show histological signs and some aspects of ageing in a 3D skin equivalent in vitro, which mimics aged skin in vivo.


Archive | 2008

Skin and skin models

Olaf Holtkötter; Dirk Petersohn

Skin inflammation is an often-occurring phenomenon in a wide range of skin pathologies. In order to understand the basics of the underlying molecular mechanisms, early responses such as gene expression changes in this tissue are the focus of numerous studies. The prerequisite for gene expression analysis is the isolation of relevant tissue samples and the subsequent preparation of high quality RNA.


Archive | 2006

Topical cosmetic and dermatological composition containing alkylurea and other active agent, useful for treating e.g. ageing of the skin and pigmentation disorders

Thomas Döring; Barbara Heide; Olaf Holtkötter; Anemone Träger; Armin Wadle; Marianne Waldmann-Laue; Gabriele Weser


Archive | 2005

Cosmetic or dermatological composition for topical skin treatment, used e.g. to increase epidermal thickness, contains a Vitamin B6 component and a compound that stimulates collagen synthesis

Olaf Holtkötter; Claudia Jassoy; Daniela Keßler-Becker; Anemone Träger; Marianne Waldmann-Laue


Archive | 2013

Water-soluble packaging with a bittering agent

Frank Meier; Martina Hermann; Olaf Holtkötter; Matthias Sunder; Brigitte Giesen


Archive | 2008

Cellular rejuvenation compounds

Olaf Holtkötter; Waltraud Knieps-Massong; Kerstin Elias; Frank Janssen; Claudia Jassoy; Anke Kolbe; Ursula Engels; Marianne Waldmann-Laue; Anemone Träger; Soraya Heinen


Archive | 2006

Cosmetic or dermatological topical composition contains oligopeptide derivative and apple extract, useful for treating e.g. wrinkles, creases and aging

Thomas Döring; Olaf Holtkötter; Marianne Waldmann-Laue


Archive | 2006

Cosmetic and dermatological compositions containing oligopeptides and apple extract

Olaf Holtkötter; Marianne Waldmann-Laue; Thomas Döring

Collaboration


Dive into the Olaf Holtkötter's collaboration.

Researchain Logo
Decentralizing Knowledge